Last $43.76 USD
Change Today +0.73 / 1.70%
Volume 557.7K
WST On Other Exchanges
New York
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

west pharmaceutical services (WST) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/17/14 - $51.12
52 Week Low
04/18/13 - $31.35
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

west pharmaceutical services (WST) Related Businessweek News

No Related Businessweek News Found

west pharmaceutical services (WST) Details

West Pharmaceutical Services, Inc. develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The Pharmaceutical Packaging Systems segment offers packaging components and systems for injectable drug delivery, such as stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. This segment also provides contract analytical laboratory services for testing and evaluating primary drug packaging components with the contained drug formulation; and specialized testing for complete drug delivery systems. The Pharmaceutical Delivery Systems segment offers safety and administration systems, and multi component systems for drug administration. This segment offers customer contract-manufacturing and assembly solutions, which include technologies, such as multi-component molding, in-mold labeling, ultrasonic welding, and clean room molding and device assembly used to manufacture customer-owned components, as well as devices used in surgical, diagnostic, ophthalmic, other drug delivery systems, personal care, and consumer products. This segment’s administration systems comprise sterile devices for the administration of drug products, including transfer devices, needleless reconstitution systems, and vial adapters. The company sells its products through its sales force, distribution network, contract sales agents, and regional distributors in the United States, Germany, France, and other European countries. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

6,900 Employees
Last Reported Date: 02/27/14
Founded in 1923

west pharmaceutical services (WST) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $825.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $457.9K
President of Pharmaceutical Packaging Systems
Total Annual Compensation: $394.8K
President of Pharmaceutical Packaging Systems...
Total Annual Compensation: $359.3K
President of Pharmaceutical Delivery Systems
Total Annual Compensation: $339.9K
Compensation as of Fiscal Year 2013.

west pharmaceutical services (WST) Key Developments

West Pharmaceutical Services, Inc. Announces Resignation of Robert Johnson from the Board of Directors Effective April 30, 2014

Robert Johnson notified the West Pharmaceutical Services, Inc. that he will be retiring from the board of directors effective April 30, 2014. Mr. Johnson was scheduled to retire on May 6, 2014 in accordance with the board's mandatory retirement policy.

West Pharmaceutical Services, Inc. Presents at Barclays Capital 2014 Global Healthcare Conference, Mar-13-2014 09:00 AM

West Pharmaceutical Services, Inc. Presents at Barclays Capital 2014 Global Healthcare Conference, Mar-13-2014 09:00 AM. Venue: Loews Miami Beach Hotel, Miami, Florida, United States. Speakers: William J. Federici, Chief Financial Officer and Senior Vice President.

West Pharmaceutical Services Appoints Myla Lai-Goldman to its Board of Directors; Announces Second Quarter 2014 Dividend Payable on May 7, 2014

West Pharmaceutical Services, Inc. announced that its Board of Directors increased the size of the board to eleven and appointed Myla Lai-Goldman, M.D., for a term that will expire at the 2014 Annual Meeting of Shareholders, when she will stand for election. Dr. Lai-Goldman, 56, is Chief Executive Officer and President of GeneCentric Diagnostics, Inc., and also a founder and director. The board also approved payment of the second-quarter 2014 cash dividend of $0.10 per share. The dividend will be paid on May 7, 2014 to shareholders of record on April 23, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WST:US $43.76 USD +0.73

WST Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chemed Corp $87.26 USD -0.79
Hill-Rom Holdings Inc $36.66 USD -0.12
Sirona Dental Systems Inc $74.29 USD -0.11
STERIS Corp $49.48 USD -0.07
Teleflex Inc $101.84 USD -0.34
View Industry Companies

Industry Analysis


Industry Average

Valuation WST Industry Range
Price/Earnings 27.4x
Price/Sales 2.2x
Price/Book 3.3x
Price/Cash Flow 27.1x
TEV/Sales 1.8x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WEST PHARMACEUTICAL SERVICES, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at